EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway

Zhaoping Qiu, Weijie Guo, Bo Dong, Yu Wang, Pan Deng, Chi Wang, Jinpeng Liu, Qing Zhang, Rudolf Grosschedl, Zhiyong Yu, Jiong Deng, Yadi Wu

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Early B cell factor 1 (EBF1) is a transcriptional factor with a variety of roles in cell differentiation and metabolism. However, the functional roles of EBF1 in tumorigenesis remain elusive. Here, we demonstrate that EBF1 is highly expressed in triple-negative breast cancer (TNBC). Furthermore, EBF1 has a pivotal role in the tumorigenicity and progression of TNBC. Moreover, we found that depletion of EBF1 induces extensive cell mitophagy and inhibits tumor growth. Genome-wide mapping of the EBF1 transcriptional regulatory network revealed that EBF1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that fine-tunes the expression of HIF1α targets via suppression of p300 activity. EBF1 therefore holds HIF1α activity in check to avert extensive mitophagy-induced cell death. Our findings reveal a key function for EBF1 as a master regulator of mitochondria homeostasis in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.

Original languageEnglish (US)
Article numbere2119518119
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number28
StatePublished - Jul 12 2022


  • EBF1
  • HIF1α
  • TNBC
  • homeostasis
  • mitophagy

ASJC Scopus subject areas

  • General


Dive into the research topics of 'EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway'. Together they form a unique fingerprint.

Cite this